New York, NY, United States of America

Stemline Therapeutics, Inc.


USPTO Granted Patents = 11


Trademarks = 1

Forward Citations = 25

Loading Chart...
Loading Chart...

3 inventors (with patents filed for the assignee):

goldMedal Ivan Bergstein (11 out of 20 patents)

silverMedal Thomas P Cirrito (3 out of 4 patents)

bronzeMedal Christopher Brooks (3 out of 4 patents)


11 patents:

Company Overview
Stemline Therapeutics, Inc. is a biopharmaceutical company based in New York, specializing in the development of innovative therapies for cancer treatment. The company focuses on advancing novel drug candidates that target specific pathways involved in tumor growth and survival. With a commitment to addressing unmet medical needs, Stemline leverages its expertise in oncology to create transformative therapies aimed at improving patient outcomes. Its research initiatives are centered on precision medicine and targeted therapies, contributing to the evolving landscape of cancer care.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

11 Patents

#642 in New York, NY

#1,598 in New York

#27,514 in US

#51,761 in the World

New York, NY (US)
New York, NY, United States of America
Forward Citations = 25

3 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Stemline Therapeutics, Inc.. Retrieved from https://idiyas.com/company/stemline-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…